Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$93.4K Sell
20,399
-10
-0% -$53 ﹤0.01% 4048
2025
Q4
$115K Hold
20,409
﹤0.01% 4537
2025
Q3
$157K Sell
20,409
-15,031
-42% -$114K ﹤0.01% 4434
2025
Q2
$245K Buy
35,440
+20,667
+140% +$135K ﹤0.01% 4158
2025
Q1
$87K Sell
14,773
-17,350
-54% -$112K ﹤0.01% 4455
2024
Q4
$219K Buy
32,123
+5,742
+22% +$34.9K ﹤0.01% 4264
2024
Q3
$166K Buy
26,381
+20,913
+382% +$124K ﹤0.01% 4387
2024
Q2
$34.1K Buy
+5,468
New +$32.8K ﹤0.01% 4335

Other funds holding RNW

Barclays's RNW Position: Q1 2026 in Review

Barclays reduced its ReNew (RNW) stake by 0.05% in Q1 2026, selling an estimated $53 and leaving 20,399 shares worth $93.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4048.

Barclays first reported a position in RNW in Q2 2024 and has held it in 8 quarters since. The position peaked at $245K in Q2 2025. 113 funds tracked by Wall St. Rank hold RNW as of Q1 2026.

  • Barclays held 20,399 shares of ReNew worth $93.4K as of Q1 2026.
  • Barclays sold 10 ReNew shares in Q1 2026, an estimated $53.
  • ReNew made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #4048 holding.
  • Barclays first reported a position in ReNew in Q2 2024 and has held it in 8 quarters since.
  • Barclays's ReNew position peaked at $245K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held ReNew as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.